[Protective effect of Sm 857 (Doqualast) in allergic bronchial asthma].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*; D011897:Random Allocation; D012130:Respiratory Hypersensitivity / Q000188:drug therapy*
D011799:Quinazolines; C051309:doqualast
Die protektive Wirkung des Sm 857 (Doqualast) bei allergischem Asthma bronchiale.